Binkui Li

Academic / Other · 1 registered clinical trial.

Status	Trial	Phase	Started
Unknown	HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma	Phase 2	2023-05-31